
Odaberite svoju etiketu
prikazano izravno na bočiciRAD-140 (Testolone)
SARMs
- Šalje se iz Njemačke
Narudžba
- DHL s praćenjem
- Diskretno pakiranje
4.6 od 5 na Trustpilotu73 recenzija
Traženo i kao: Testolon
Na prvi pogled
RAD-140 (Testolone) u brojkama
Ključni podaci iz našeg leksikona. Povucite točku po krivulji i pogledajte koliko, prema izračunu, ostaje nakon jedne doze.
Cijeli članak u leksikonuHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~1.9 days
Simplified model without an absorption phase, half-life from the TPD lexicon.
Half-life
44.7hours
measured in humans
- Class
- SARMnon-steroidal
- Use
- Oraldaily
- Sizes
- 10 mg1 size in the shop
What studies show
All 4 sources in the lexicon- Miller et al., ACS Medicinal Chemistry Letters, 2011
RAD140 inhibits the growth of AR-positive breast cancer models (preclinical) (opens in a new tab)
Yu et al., Clinical Cancer Research, 2017Documented case of liver injury under RAD-140 outside clinical trials (opens in a new tab)
Ladna et al., Journal of Medical Case Reports, 2023
Recenzije
Što kažu kupci
Samo stvarne narudžbe koje su uključivale RAD-140 (Testolone).
Sve recenzijeZa RAD-140 (Testolone) još nema laboratorijske analize. Glasaj za toDajte sami na testiranje, mi plaćamo polaSve laboratorijske analize
Znanje
Sve o RAD-140 (Testolone)
Detaljne informacije uskoro.
How does RAD-140 work?
According to ChEMBL RAD-140 binds to the androgen receptor with a Ki of 7 nM and activated it in muscle cells in the lab. Yu and colleagues found that it activates the receptor in breast cancer cells but not in prostate cancer cells. That is the tissue preference SARMs aim for.
Is RAD-140 approved?
No. On ClinicalTrials.gov there is a single study for RAD140, the completed phase 1 study in breast cancer (as of 26 October 2026). There are no studies in healthy people. Everything here is the state of research, not a recommendation.
What did the phase 1 study show?
22 heavily pretreated women with breast cancer took RAD-140 daily. SHBG fell in all 18 women measured, PSA rose in 16 of 20, a sign of action at the receptor. After 24 weeks 18.2 percent had a benefit, one woman a partial response. Liver values rose often.
What about the liver?
In the phase 1 study AST rose in 59.1 percent, ALT in 45.5 percent. In addition there are case reports. A 26-year-old had acute liver injury, his values normalised two months after stopping. A 24-year-old developed cholestatic liver injury after five weeks of use.
Are there reports on the heart?
Yes, as a case report: Padappayil and colleagues describe a young man with possible acute myocarditis after self-use of RAD-140 for bodybuilding. A case report does not prove a link, but it shows what to watch for.
Is muscle gain proven in humans?
No. The first description by Miller and colleagues shows anabolic effects in animal models. In humans there is only the phase 1 study in women with breast cancer, which did not measure muscle mass.
Usporedbe
Kako se uspoređuje
Povezano
Srodni proizvodi
MK-677 (Ibutamoren)
SARM-ovi i sagorijevači masti · SARMs SARM-ovi i sagorijevači masti · SARMs
1 veličina
LGD-4033 (Ligandrol)
SARM-ovi i sagorijevači masti · SARMs SARM-ovi i sagorijevači masti · SARMs
1 veličina
Ostarine (MK-2866)
SARM-ovi i sagorijevači masti · SARMs SARM-ovi i sagorijevači masti · SARMs
1 veličina
GW-501516 (Cardarine)
SARM-ovi i sagorijevači masti · SARMs SARM-ovi i sagorijevači masti · SARMs
1 veličina
RAD-140 (Testolone)

